(NASDAQ: ALKS) announced today that it will webcast its Research and Development (R&D) Day presentation on Wednesday, July 17, 2013. The webcast will begin at 1:00 p.m. EDT (6:00 p.m. BST). At the meeting, members of Alkermes’ senior management will provide detailed information on the company’s lead clinical programs, discuss its distinctive R&D strategy and introduce new product candidates.
A live webcast of the event will be available on the Investors tab of the company’s website at
. To ensure a timely connection to the webcast, it is recommended that users register at least 15 minutes prior to the scheduled start. This webcast will be archived on Alkermes’ website for one month.
Alkermes plc is a fully integrated, global biopharmaceutical company that applies its scientific expertise and proprietary technologies to develop innovative medicines that improve patient outcomes. The company has a diversified portfolio of more than 20 commercial drug products and a substantial clinical pipeline of product candidates that address central nervous system (CNS) disorders such as addiction, schizophrenia and depression. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and manufacturing facilities in Gainesville, Georgia and Wilmington, Ohio. For more information, please visit Alkermes’ website at